Sung Won Kwon

Sung Won Kwon

Auto-generated profile, based on publicly available information

Sung Won Kwon

Department of Surgery, CHA Bundang Medical Center, CHA University, Seongnam, Korea

Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 September 2010 in Journal of Cellular Biochemistry
Verified
Journal Article
Closed access
PDF file
MLMin‐Jae Lee
Min‐Jae Lee
JJJieun Jung
Jieun Jung
KNKyu‐Hwan Na
Kyu‐Hwan Na
JMJi Suk Moon
Ji Suk Moon
HLHey‐Jin Lee
Hey‐Jin Lee
Gi Jin KimGi Jin Kim
Gi Jin Kim

1 August 2012 in Gene
Verified
Journal Article
Closed access
WKWon Hee Kim
Won Hee Kim
KMKyung Tae Min
Kyung Tae Min
YJYoung Joo Jeon
Young Joo Jeon
CKChang-Il Kwon
Chang-Il Kwon
KKKwang Hyun Ko
Kwang Hyun Ko
NKNam Keun Kim
Nam Keun Kim

20 November 2007 in International Journal of Cancer
Verified
Journal Article
Closed access
PDF file
EPEun Taek Park
Eun Taek Park
JGJames R. Gum
James R. Gum
SKSanjay Kakar
Sanjay Kakar
SKSung Won Kwon
Sung Won Kwon
GDGuoren Deng
Guoren Deng
YKYoung S. Kim
Young S. Kim

11 June 2014 in Nutrition Journal
Verified
Journal Article
Open access
PDF file
NRNa Hee Ryu
Na Hee Ryu
YLYeni Lim
Yeni Lim
JPJi Eeun Park
Ji Eeun Park
JKJoohee Kim
Joohee Kim
JKJi Yeon Kim
Ji Yeon Kim
Oran KwonOran Kwon
Oran Kwon
Background: High level of serum cholesterol is considered to be a major risk factor for cardiovascular disease (CVD). A double-blinded, randomized, placebo-controlled trial was performed to test the hypothesis that a daily intake of Chlorella may improve serum lipid profile through enhancement of serum carotenoid concentration in mildly hypercholesterolemic subjects. Methods: Eligible subjects (n = 63) were randomized to either Chlorella (5 g/day) or placebo for a double-blinded trial with a 2-week lead-in period and a 4-week intervention period. Serum triglycerides, total cholesterol, lipoproteins, apolipoproteins and carotenoids were assessed at the beginning and the end of the trial. Results: Compared with the control group, the Chlorella group exhibited remarkable changes in total cholesterol (Chlorella −1.6%; placebo 0.03%; P = 0.036), triglycerides (Chlorella −10.3%; placebo 11.9%; P = 0.002), lutein/zeaxanthin (Chlorella 89.6%; placebo −1.7%; P < 0.0001), and α-carotene (Chlorella 163.6%; placebo 15%; P < 0.0001). Improvement of serum lipids was supported by significant reductions of very low-density lipoprotein cholesterol (Chlorella −11%; placebo 11.8%; P = 0.006), apolipoprotein B (Chlorella −1.5%; placebo 1.7%; P = 0.044), non high-density lipoprotein (Chlorella −2.6%; placebo −0.5%; P = 0.032), and high-density lipoprotein/triglycerides (Chlorella 4.0%; placebo −9.5%; P = 0.023), suggesting an inhibitory effect of Chlorella on the intestinal absorption of dietary and endogenous lipids. Further, the changes of serum lipids appeared to be associated with the changes of serum carotenoids. Conclusion: Daily consumption of Chlorella supplements provided the potential of health benefits reducing serum lipid risk factors, mainly triglycerides and total cholesterol, in mildly hypercholesterolemic subjects. The effect was related to carotenoid consumption. Trial registration: WHO International Clinical Trials Registry Platform KCT0000259.

1 January 2003 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
WNWan Namkung
Wan Namkung
JLJin Ah Lee
Jin Ah Lee
WAWooin Ahn
Wooin Ahn
WHWonSun Han
WonSun Han
SKSung Won Kwon
Sung Won Kwon
MLMin Goo Lee
Min Goo Lee
Pancreatic duct cells secrete bicarbonate-rich fluids, which are important for maintaining the patency of pancreatic ductal trees as well as intestinal digestive function. The bulk of bicarbonate secretion in the luminal membrane of duct cells is mediated by a Cl−-dependent mechanism (Cl−/HCO exchange), and we previously reported that the mechanism is CFTR-dependent and cAMP-activated (Lee, M. G., Choi, J. Y., Luo, X., Strickland, E., Thomas, P. J., and Muallem, S. (1999)J. Biol. Chem. 274, 14670–14677). In the present study, we provide comprehensive evidence that calcium signaling also activates the same CFTR- and Cl−-dependent HCO transport. ATP and trypsin evoked intracellular calcium signaling in pancreatic duct-derived cells through the activation of purinergic and protease-activated receptors, respectively. Cl−/HCO exchange activity was measured by recording pHi in response to [Cl−]o changes of the perfusate. In perfusate containing high concentrations of K+, which blocks Cl− movement through electrogenic or K+-coupled pathways, ATP and trypsin highly stimulated luminal Cl−/HCO exchange activity in CAPAN-1 cells expressing wild-type CFTR, but not in CFPAC-1 cells that have defective (ΔF508) CFTR. Notably, adenoviral transfection of wild-type CFTR in CFPAC-1 cells completely restored the stimulatory effect of ATP on luminal Cl−/HCO exchange. In addition, the chelation of intracellular calcium by 1,2-bis(2-aminophenoxy)ethane-N,N,N,N′-tetraacetic acid (BAPTA) treatment abolished the effect of calcium agonists on luminal Cl−/HCO exchange. These results provide a molecular basis for calcium-induced bicarbonate secretion in pancreatic duct cells and highlight the importance of CFTR in epithelial bicarbonate secretion induced by various stimuli.

1 March 2015 in Journal of Medicinal Food
Verified
Journal Article
Closed access
JKJi Yeon Kim
Ji Yeon Kim
HOHyang Mok Ok
Hyang Mok Ok
JKJoohee Kim
Joohee Kim
SPSeok Won Park
Seok Won Park
SKSung Won Kwon
Sung Won Kwon
OKOran Kwon
Oran Kwon
This study was a randomized, double-blind placebo-controlled trial to assess the efficacy of 4 weeks of mulberry leaf aqueous extract (MLAE) supplementation (5 g/day) for postprandial glycemic control in 36 subjects with impaired fasting glucose (IFG) tolerance. Postprandial responses in the glucose, insulin, and C-peptide levels were measured after a carbohydrate load both at baseline and after 4 weeks of MLAE supplementation. The postprandial glycemic response was attenuated in the MLAE group after the treatment period, particularly 30 and 60 min after loading ( P =.003 and 0.0325 for glucose, P =.0005 and .0350 for insulin, and P =.0151 and .0864 for C-peptide). Additionally, the incremental area under the curve for insulin was significantly lower in the MLAE group than in the placebo group ( P =.0207). Four weeks of MLAE supplementation improved postprandial glycemic control in individuals with IFG tolerance.